(2026). Integrated analysis identifies a palmitoylation-associated prognostic model (ACSM5/SKA3) for lung adenocarcinoma across multiple cohorts. PeerJ.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Integrated Analysis Identifies a Palmitoylation-associated Prognostic Model (ACSM5/SKA3) for Lung Adenocarcinoma Across Multiple Cohorts."
PeerJ 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Integrated Analysis Identifies a Palmitoylation-associated Prognostic Model (ACSM5/SKA3) for Lung Adenocarcinoma Across Multiple Cohorts."
PeerJ, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.